期刊文献+

乳腺癌易感基因1、2在散发性乳腺癌中的表达及意义 被引量:3

Significance and expressions of BRCA1 and BRCA2 protein in sporadic breast cancer
原文传递
导出
摘要 目的:探讨乳腺癌易感基因1( BRCA1)和乳腺癌易感基因2( BRCA2)蛋白表达在散发性乳腺癌中的作用。方法收集86例乳腺癌及癌旁组织、48例乳腺增生症手术标本,采用免疫组织化学S-P法检测BRCA1及BRCA2蛋白在各例中的表达情况。结果 BRCA1表达在乳腺癌、乳腺癌旁组织、乳腺增生症中的阳性率分别为60.5%(52/86)、46.5%(40/86)和100%(48/48),3组间比较,差异有统计学意义( P<0.01)。 BRCA2表达在乳腺癌、乳腺癌旁组织、乳腺增生症中的阳性率分别为41.9%(36/86)、55.8%(48/86)和95.8%(46/48),3组间比较,差异有统计学意义( P <0.01)。乳腺癌组织中BRCA1与BRCA2蛋白表达之间无显著性相关( r=0.673,P>0.05)。结论BRCA1和BRCA2蛋白异常表达在散发性乳腺癌发生、发展过程中起着一定作用。 Objective To explore the role of expressions of BRCA 1 and BRCA2 protein in sporadic breast cancer.Methods Eighty-six cases of breast cancer and adjacent cancer tissues and 48 cases of breast hyperplasia surgical specimens were collected . And the immunohistochemical S-P method was employed for detecting the protein expressions of BRCA 1 and BRCA2.Results BRCA1 expression in breast cancer, breast cancer adjacent cancer tissues and positive rates in breast hyperplasia were 60.5%(52/86), 46.5%( 40/86 ) and 100%( 48/48 ) .The difference was significant among three groups .The BRCA2 expression in breast cancer , breast cancer adjacent cancer tissues and positive rates in breast hyperplasia were 41.9%( 36/86 ) , 55.8%( 48/86 ) and 95.8%( 46/48 ) respectively. And the difference was significant among three groups .The expression of BRCA1 had no obvious relation with BRCA 2 protein in breast cancer tissues (r=0.673, P〉0.05).Conclusion The aberrant expressions of BRCA1 and BRCA2 protein plays a major role in the occurrence and progression of sporadic breast cancer .
作者 马金柱 刘明
出处 《中华医学杂志》 CAS CSCD 北大核心 2014年第44期3515-3518,共4页 National Medical Journal of China
基金 内蒙古自治区自然科学基金(2011MS1116)
关键词 乳腺肿瘤 BRCA1蛋白 BRCA2蛋白 免疫组织化学 Breast neoplasms BRCA1 protein BRCA2 protein Immunohistochemistry
  • 相关文献

参考文献13

  • 1Miki Y, Swensen J, Shattulk-Eidens D, et al. Astrony candidate for the breast cancer and ovarion cancer susceptibility gene BRCA1 [J]. Science, 1994, 266: 66-71.
  • 2Struewing IP, Hartge P, Wacholders, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews[ J]. N Engl J Med, 1997, 336 : 1401-1408.
  • 3Yang Q, Sakurai T, Moil I, et al. Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas [ J ]. Cancer, 2001,92: 54-60.
  • 4Lee WY, Jin YT, Chang TW, et al. Immunolocalization of BRCA1 protein in normol breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological Parameters [ J ]. Histopatbology, 1999, 34: 106-120.
  • 5Easton DF, Ford D, Bishop DT. Breast and ovarion cancer incidence in BRCAl-mutation cariesrs [ J]. Am J Hum Genet, 1995, 56:265-271.
  • 6Chen Y, Chen CF, Riley DJ, et al. Aberrant subcellular localization of BRCA1 in Breast Cancer[ J]. Science, 1995, 270: 789-791.
  • 7Seully R, Geaesan S, Brown M, et al. Location of BRCA1 in human breast and ovarian cancer cells[ J]. Science, 1996, 272: 123-126.
  • 8Junran Zhang, Simon N. The role of the BRCA1 tumor suppressor in DNA double-strand break repair [ J ]. Mol Cancer Res, 2005, 3:513-519.
  • 9许燕云,刘标,唐慰萍,吴艳霞.散发性乳腺癌中BRCA1和cyclinB1的表达[J].临床与实验病理学杂志,2004,20(3):273-276. 被引量:12
  • 10Thompson ME, Jensen RA, Obermiller PS, et al. Decreased expression of BRCA1 accelerates grow and is often present during sporadic breast cancer progression. Mutation of the BRCA1 gene in human cancer[ J]. Nature Genet, 1995, 9: 444-446.

二级参考文献36

  • 1Lee WY, Jin YT, Chang TW, et al. Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: a correlation with other biological parameters. Histopathology, 1999,34(2):106~12.
  • 2Takeno S, Noguchi T, Kikuchi R, et al. Prognostic value of cyclinB1 in patients with esophageal squamous cell carcinoma. Cancer, 2002,94(11): 2874~81.
  • 3Soria JC, Jang SJ, Khuri FR, et al. Overexpression of cyclinB1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res, 2000,60(15): 4000~4.
  • 4Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, 1994, 266:66~71.
  • 5Yang Q, Sakurai T, Mori I, et al. Prognostic significance of BRCA1 expression in Japanese sporadic breast carcinomas. Cancer, 2001, 92(1): 54~60.
  • 6MacLachlan TK, Somasundaram K, Sgagias M, et al. BRCA1 effects on the cell cycle and the DNA damage response are linked to altered gene expression. J Biol Chem, 2000,275(4): 2777~85.
  • 7沈镇宙主编. 现代乳腺肿瘤学进展. 上海:上海科学技术文献出版社,2002:19-36.
  • 8Collecchi P, Santoni T, Gnesi E, et al. Cyclins of phases G1, S and G2/M are overexpressed in aneuploid mammary carcinomas. Cytometry, 2000,42(4):254~60.
  • 9Megha T, Lazzi S, Ferrari F, et al. Expression of the G2-M checkpoint regulators cyclinB1 and P34CDC2 in breast cancer: a correlation with cellular kinetics. Anticancer Res, 1999,19(1A):163~9.
  • 10Miyoshi Y, Iwao K, Takahashi Y, et al. Acceleration of chromosomal instability by loss of BRCA1 expression and p53 abnormality in sporadic breast cancers. Cancer Lett, 2000,159(2):211~6.

共引文献26

同被引文献26

  • 1周冬仙,徐红先,熊文,邵超鹏.乳腺癌患者高频BRCA1等位基因研究[J].中华实验外科杂志,2005,22(5):530-531. 被引量:3
  • 2邹晓,魏涛,宋修岐,薛龙.乳癌相关分子标记物研究进展[J].青岛大学医学院学报,2006,42(2):185-186. 被引量:2
  • 3Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 [ J ]. Science, 1994, 266(5182) :66-71.
  • 4Ouchi T, Monteiro AN, August A, et al. BRCA1 regulates p53- dependent gene expression [ J ]. Proc Natl Acad Sci U S A, 1998, 95(5) :2302-2306.
  • 5Soueek P, Borovanova T, Pohlreieh P, et al. Role of single nueleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech ease-control study [ J]. Breast Cancer Res Treat, 2006, 103(2) :219-224.
  • 6Aloraifi F, Alshehhi M, MeDevitt T, et al. Phenotypic analysis of familial breast cancer: eomparison of BRCAx tumors withBRCAI-, BRCA2-carriers and non-familial breast cancer[J]. Eur J Surq Oncol, 2015, 41(5) : 641-646.
  • 7Yamashita N, Tokunaqa E, Kitao H, et al. Epigenetic inactivation of BRCA1 through promoter hypermethylation and its clinical importance in triple-negative breast cancer [ J ]. Clin Breast Cancer, 2015, [ Epub ahead of print]. PMID : 26195437.
  • 8Christopher RM, Calvin DR. Regulation of BRCA1 expression and its relationship to sporadic breast cancer [ J] . Breast Cancer Res, 2003, 5(1) :45-52.
  • 9Bhatti P, Church DM, Rutter JL, et al. Candidate single nueleotide polymorphism selection using publicly available tools: a guide for epidemiologists [ J ]. Am J Epidemiol, 2006, 164 (8) : 794 -804.
  • 10Nieoloso MS, Sun H, Spizzo R, et al. Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility [ J]. Cancer Res, 2010, 70(7) :2789-2798.

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部